✦ LIBER ✦

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms

✍ Scribed by Álvarez-Twose, Iván; González de Olano, David; Sánchez-Muñoz, Laura; Matito, Almudena; Esteban-López, Maria I.; Vega, Arantza; Mateo, Maria Belén; Alonso Díaz de Durana, Maria D.; de la Hoz, Belén; del Pozo Gil, Maria D.; Caballero, Teresa; Rosado, Ana; Sánchez Matas, Isabel; Teodósio, Cristina; Jara-Acevedo, María; Mollejo, Manuela; García-Montero, Andrés; Orfao, Alberto; Escribano, Luis

Book ID: 119283738
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 501 KB
Volume: 125
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2010.02.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical, Biological And Molecular Chara

Clinical, Biological And Molecular Characteristics Of Mast Cell Activation Disorders: A Prospective Study In 62 Patients By The Spanish Network On Mastocytosis (REMA).

✍ Alvarez-Twose, I.; González-Olano, D.; Sánchez-Muñoz, L.; Teodosio, C.; Jara-Ace 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Systemic mastocytosis with associated cl

Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: Analysis of clinicopathologic features and activating c-kit mutations

✍ Vinod A. Pullarkat; Carlos Bueso-Ramos; Raymond Lai; Steven Kroft; Carla S. Wils 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

## Abstract The majority of patients with systemic mastocytosis with associated clonal, hematological non‐mast cell lineage disease (SM‐AHNMD) have a myeloid stem cell malignancy including myelodysplastic syndromes (MDS), myelodysplastic/myeloproliferative disorders, acute myeloid leukemia (AML), o